-: My name's Jen Dial, I'm a global communications manager
at Eli Lilly and Company.
I work with a lot of different individuals internally
any time that we're getting ready to do something external,
so any time, I work with media daily
and strategically work on our communication front.
Whether that's putting together our communication plans,
whether it's our press releases, our data milestones,
so different phases of research we have to announce
at a certain time, and with that announcement
I work with our legal, I'll work with our investor relations
I work with our different medical folks
and kind of piecing together everything that we need
to be talking about externally.
Different data milestones, different communication campaigns
that we have, FDA approvals, and work closely
with our marketing peers and everything
and our social media as well.
There's a lot of different components that work into it.
Basically, you know, one of the roles that I'm in
is that there are millions of patients out there
who have an unmet need and there isn't something currently
on the market that is helping them with their pain
or helping them with their certain disease state
and part of my area is that I help
with that communication side
and bring that out and to the media.
Bring it out to the different stakeholders,
whether that's different physician groups,
whether it's investors, whether it's, you know,
the general media, if it's trade media,
business media, consumer media.
There's a lot of different avenues to go through.
But, by bringing that information out there potentially
to patients or potentially to physicians
to help them understand what the options are for patients
or help bring additional education
around specific disease state is essential.
I primarily work with media.
With media, I mean anything that is an earned media.
It's not a paid-for advertisement like you would see
in advertising or marketing,
this is more of an earned media space.
I'm working with different reporters,
whether it's from trade, whether it's all the way up
to top tier, whether that you're talking about
Washington Post, CNN, ABC, that kind of thing
to different business outlets as well,
talking about the certain messagings that we're wanting
to get out there, whether it's for our investor community,
whether it's for the physician community,
whether it's for consumers, to understand
whether it's the disease state
or our latest data that we released on a certain area,
whether it's for migraine or a different product
that we're working on leading up to hopeful FDA approval.
And then thereafter, to help educate that special audience
that we're trying to go after and understanding
what we're trying to communicate to them.